666

JIANGXI TIANXIN PHARMACEUTICAL

No trades
See on Supercharts
Market capitalization
‪11.67 B‬CNY
‪475.85 M‬CNY
‪1.86 B‬CNY
‪11.95 M‬
Beta (1Y)
1.16

About JIANGXI TIANXIN PHARMACEUTICAL

CEO
Xiaobing Yu
Headquarters
Leping
Employees (FY)
‪2.47 K‬
Founded
2004
ISIN
CNE100005Q89
FIGI
BBG011PVGDQ6
JiangXi Tianxin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of monomeric vitamins. Its products include vitamin B6, vitamin B1, biotin, folic acid, vitamin D3, ascorbyl palmitate, and vitamin E powder. The company was founded on September 24, 2004 and is headquartered in Leping, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 603235 is 27.44 CNY — it has increased by 2.96% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange JIANGXI TIANXIN PHARMACEUTICAL stocks are traded under the ticker 603235.
603235 stock is 5.72% volatile and has beta coefficient of 1.16. Check out the list of the most volatile stocks — is JIANGXI TIANXIN PHARMACEUTICAL there?
Yes, you can track JIANGXI TIANXIN PHARMACEUTICAL financials in yearly and quarterly reports right on TradingView.
603235 stock has risen by 4.53% compared to the previous week, the month change is a 19.88% rise, over the last year JIANGXI TIANXIN PHARMACEUTICAL has showed a 5.28% decrease.
603235 net income for the last quarter is ‪62.95 M‬ CNY, while the quarter before that showed ‪82.95 M‬ CNY of net income which accounts for −24.11% change. Track more JIANGXI TIANXIN PHARMACEUTICAL financial stats to get the full picture.
Yes, 603235 dividends are paid annually. The last dividend per share was 0.71 CNY. As of today, Dividend Yield (TTM)% is 2.59%. Tracking JIANGXI TIANXIN PHARMACEUTICAL dividends might help you take more informed decisions.
JIANGXI TIANXIN PHARMACEUTICAL dividend yield was 2.08% in 2023, and payout ratio reached 46.00%. The year before the numbers were 2.44% and 49.96% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 603235 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade JIANGXI TIANXIN PHARMACEUTICAL stock right from TradingView charts — choose your broker and connect to your account.
603235 reached its all-time high on Jul 12, 2022 with the price of 53.11 CNY, and its all-time low was 19.13 CNY and was reached on Feb 5, 2024.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has ‪2.47 K‬ employees. See our rating of the largest employees — is JIANGXI TIANXIN PHARMACEUTICAL on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So JIANGXI TIANXIN PHARMACEUTICAL technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating JIANGXI TIANXIN PHARMACEUTICAL stock shows the neutral signal. See more of JIANGXI TIANXIN PHARMACEUTICAL technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. JIANGXI TIANXIN PHARMACEUTICAL EBITDA is ‪550.23 M‬ CNY, and current EBITDA margin is 29.56%. See more stats in JIANGXI TIANXIN PHARMACEUTICAL financial statements.